RE:RE:ONCY's pelareorep enables CAR-T trafficking in solid tumorsA recently published paper in the New England Journal of Medicine dated February 21, 2024, found that CD19 CAR T-cell transfer appeared to be feasible, safe, and efficacious in three different autoimmune diseases, systemic lupus erythematosus (SLE), idiopathic inflammatory myositis, and systemic sclerosis.
https://www.nejm.org/doi/full/10.1056/NEJMoa2308917